Comparing Abbott m2000 RealTime HIV test and Roche COBAS Ampliprep/COBAS Taqman HIV test, v2.0 in treated HIV-1 B and non-B subjects with low viraemia

Journal of Medical Virology

Volumn 88, Issue 4, 2016, Pages 724-727

  Margariti, Apostolia ^a   Chatzidimitriou, Dimitrios ^a   Metallidis, Simeon ^a   Pilalas, Dimitrios ^a   Kourelis, Andreas ^a   Papadimitriou, Evangelia ^a   Haidich, Anna Bettina ^a   Malisiovas, Nicolaos ^a   Skoura, Lemonia ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Agreement study; HIV subtype; Real time PCR; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL DECISION MAKING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE B; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE NON B; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATIENT MONITORING; POLYMERASE CHAIN REACTION SYSTEM; REAL TIME POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS LOAD; BLOOD; CLASSIFICATION; COMPARATIVE STUDY; DRUG MONITORING; EVALUATION STUDY; GENETICS; GENOTYPE; HIV INFECTIONS; ISOLATION AND PURIFICATION; MOLECULAR DIAGNOSIS; PROCEDURES; VIROLOGY;

BLOOD; DRUG MONITORING; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; VIRAL LOAD;

EID: 84955682831     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24369     Document Type: Article

References (22)

1. Bland JM, Altman DG. 1999. Measuring agreement in method comparison studies. Stat Methods Med Res 8:135-160.
2. Boillat-Blanco N, Darling KE, Schoni-Affolter F, Vuichard D, Rougemont M, Fulchini R, Bernasconi E, Aouri M, Clerc O, Furrer H, Günthard HF, Cavassini M; Swiss HIV Cohort Study. 2014. Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study. Antivir Ther 20:165-175.
3. Bourlet T, Signori-Schmuck A, Roche L, Icard V, Saoudin H, Trabaud M-A, Tardy J-C, Morand P, Pozzetto B, Ecochard R, André P. 2011. HIV-1 load comparison using four commercial real-time assays. J Clin Microbiol 49:292-297.
4. Charpentier C, Choquet M, Joly V, Yeni P, Visseaux B, Caseris M, Brun-Vézinet F, Yazdanpanah Y, Peytavin G, Descamps D, Landman R. 2014. Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay. J Antimicrob Chemother 69:2819-2825.
5. Charpentier C, Landman R, Laouénan C, Joly V, Hamet G, Damond F, Brun-Vézinet F, Mentré F, Descamps D, Yeni P. 2012. Persistent low-level HIV-1 RNA between 20 and 50 copies/ml in antiretroviral-treated patients: associated factors and virological outcome. J Antimicrob Chemother 67:2231-2235.
6. Church D, Gregson D, Lloyd T, Klein M, Beckthold B, Laupland K, Gill MJ. 2011. Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections. J Clin Microbiol 49:118-124.
7. Do T, Duncan J, Butcher A, Liegler T. 2011. Comparative frequencies of HIV low-level viremia between real-time viral load assays at clinically relevant thresholds. J Clin Virol 52:S83-S89.
8. Doyle T, Smith C, Vitiello P, Cambiano V, Johnson M, Owen A, Phillips AN, Geretti AM. 2012. Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy. Clin Infect Dis 54:724-732.
9. Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P, Saag MS, Thomas DL, Jacobsen DM, Volberding PA; International Antiviral Society-USA Panel. 2014. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel. JAMA 312:410-425.
10. Hemelaar J, Gouws E, Ghys PD, Osmanov S; WHO-UNAIDS Network for HIV Isolation and Characterisation. 2011. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 25:679-689.
11. Kottner J, Audigé L, Brorson S, Donner A, Gajewski BJ, Hróbjartsson A, Roberts C, Shoukri M, Streiner DL. 2011. Guidelines for reporting reliability and agreement studies (GRRAS) were proposed. J Clin Epidemiol 64:96-106.
12. Laprise C, de Pokomandy A, Baril JG, Dufresne S, Trottier H. 2013. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: Results from 12 years of observation. Clin Infect Dis 57:1489-1496.
13. Loutfy MR, Sherr L, Sonnenberg-Schwan U, Walmsley SL, Johnson M, d'Arminio Monforte A; Women for Positive Action. 2013. Caring for women living with HIV: Gaps in the evidence. J Int AIDS Soc 16:18509.
14. Ruelas DS, Greene WC. 2013. An integrated overview of HIV-1 latency. Cell 155:519-529.
15. Scherrer AU, Ledergerber B, von Wyl V, Böni J, Yerly S, Klimkait T, Bürgisser P, Rauch A, Hirschel B, Cavassini M, Elzi L, Vernazza PL, Bernasconi E, Held L, Günthard HF; Swiss HIV Cohort Study. 2011. Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B. Clin Infect Dis 53:1143-1152.
16. Sire JM, Vray M, Merzouk M, Plantier JC, Pavie J, Maylin S, Timsit J, Lascoux-Combe C, Molina JM, Simon F, Delaugerre C. 2011. Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays. J Acquir Immune Defic Syndr 56:239-243.
17. Skoura L, Metallidis S, Pilalas D, Kourelis A, Margariti A, Papadimitriou E, Antoniadou ZA, Chrysanthidis T, Tsachouridou O, Kollaras P, Nikolaidis P, Malisiovas N. 2013. High rates of transmitted drug resistance among newly-diagnosed antiretroviral naive HIV patients in Northern Greece, data from 2009-2011. Clin Microbiol Infect 19:E169-E172.
18. Sollis KA, Smit PW, Fiscus S, Ford N, Vitoria M, Essajee S, Barnett D, Cheng B, Crowe SM, Denny T, Landay A, Stevens W, Habiyambere V, Perrins J, Peeling RW. 2014. Systematic review of the performance of HIV viral load technologies on plasma samples. PLoS One 9:e85869.
19. Swenson LC, Cobb B, Geretti AM, Harrigan PR, Poljak M, Seguin-Devaux C, Verhofstede C, Wirden M, Amendola A, Boni J, Bourlet T, Huder JB, Karasi JC, Zidovec Lepej S, Lunar MM, Mukabayire O, Schuurman R, Tomazic J, Van Laethem K, Vandekerckhove L, Wensing AM; International Viral Load Assay Collaboration. 2014. Comparative performances of HIV-1 RNA load assays at low viral load levels: Results of an international collaboration. J Clin Microbiol 52:517-523.
20. Touloumi G, Pantazis N, Chaix ML, Bucher HC, Zangerle R, Kran AM, Thiebaut R, Masquelier B, Kucherer C, Monforte Ad, Meyer L, Porter K; for CASCADE Collaboration in EuroCoord. 2013. Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration. PLoS One 8:e71174.
21. van Rensburg EJ, Tait K, Watt A, Schall R. 2011. Comparative evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 version 2 test using the TaqMan 48 analyzer and the Abbott RealTime HIV-1 assay. J Clin Microbiol 49:377-379.
22. Xu S, Song A, Nie J, Li X, Meng S, Zhang C, Wang Y. 2012. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China. J Clin Virol 53:33-37.